Found: 17
Select item for more details and to access through your institution.
Reactivation of Chagas Disease in a Patient With an Autoimmune Rheumatic Disease: Case Report and Review of the Literature.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 2, p. 1, doi. 10.1093/ofid/ofaa642
- By:
- Publication type:
- Article
Plant-soil processes in Eriophorum vaginatum tussock tundra in Alaska: a systems modeling approach
- Published in:
- Ecological Monographs, 1984, v. 54, n. 4, p. 361
- By:
- Publication type:
- Article
High polymorphism in the trisomic portion of a gastric cancer cell line.
- Published in:
- Journal of Gastroenterology, 2007, v. 42, n. 3, p. 196, doi. 10.1007/s00535-006-2001-0
- By:
- Publication type:
- Article
4Ei-10 interdiction of oncogenic cap-mediated translation as therapy for non-small cell lung cancer.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 3, p. 636, doi. 10.1007/s10637-020-01036-8
- By:
- Publication type:
- Article
4EGI-1 represses cap-dependent translation and regulates genome-wide translation in malignant pleural mesothelioma.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 2, p. 217, doi. 10.1007/s10637-017-0535-z
- By:
- Publication type:
- Article
Targeting Eukaryotic Translation in Mesothelioma Cells with an eIF4E-Specific Antisense Oligonucleotide.
- Published in:
- PLoS ONE, 2013, v. 8, n. 11, p. 1, doi. 10.1371/journal.pone.0081669
- By:
- Publication type:
- Article
Small-molecule inhibition of oncogenic eukaryotic protein translation in mesothelioma cells.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 4, p. 598, doi. 10.1007/s10637-014-0076-7
- By:
- Publication type:
- Article
Novel acridine-based agents with topoisomerase II inhibitor activity suppress mesothelioma cell proliferation and induce apoptosis.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 4, p. 1443, doi. 10.1007/s10637-011-9720-7
- By:
- Publication type:
- Article
Anti-proliferative effects of simocyclinone D8 (SD8), a novel catalytic inhibitor of topoisomerase II.
- Published in:
- Investigational New Drugs, 2010, v. 28, n. 1, p. 20, doi. 10.1007/s10637-008-9209-1
- By:
- Publication type:
- Article
Multiple cis-acting sites positively regulate Escherichia coli nrd expression.
- Published in:
- Molecular Microbiology, 1998, v. 28, n. 6, p. 1315, doi. 10.1046/j.1365-2958.1998.00897.x
- By:
- Publication type:
- Article
A 45 bp inverted repeat is required for cell cycle regulation of the Escherichia coli nrd operon.
- Published in:
- Molecular Microbiology, 1998, v. 28, n. 6, p. 1307, doi. 10.1046/j.1365-2958.1998.00896.x
- By:
- Publication type:
- Article
eIF4F Inhibition Sensitizes Non‐Small Cell Lung Cancer Cells to a Topoisomerase II Inhibitor.
- Published in:
- FASEB Journal, 2021, v. 35, p. N.PAG, doi. 10.1096/fasebj.2021.35.S1.01593
- By:
- Publication type:
- Article
Repression of oncogenic cap-mediated translation by 4Ei-10 diminishes proliferation, enhances chemosensitivity and alters expression of malignancy-related proteins in mesothelioma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
High-density allelotype of the commonly studied gastric cancer cell lines.
- Published in:
- Genes, Chromosomes & Cancer, 2001, v. 32, n. 1, p. 67, doi. 10.1002/gcc.1168
- By:
- Publication type:
- Article
SFPQ Promotes Lung Cancer Malignancy via Regulation of CD44 v6 Expression.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.862250
- By:
- Publication type:
- Article
Serum Splicing Factor Proline- and Glutamine-Rich Is a Diagnostic Marker for Non-Small-Cell Lung Cancer and Other Solid Cancers.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 16, p. 8766, doi. 10.3390/ijms25168766
- By:
- Publication type:
- Article
SFPQ and Its Isoform as Potential Biomarker for Non-Small-Cell Lung Cancer.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 15, p. 12500, doi. 10.3390/ijms241512500
- By:
- Publication type:
- Article